603716 塞力医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-8.615-19.508-12.135-10.371-3.085
总资产报酬率 ROA (%)-3.546-6.780-4.344-3.726-1.207
投入资产回报率 ROIC (%)-4.805-9.860-6.032-4.957-1.554

边际利润分析
销售毛利率 (%)21.73218.32919.57519.86321.075
营业利润率 (%)-9.389-7.831-8.989-6.433-0.623
息税前利润/营业总收入 (%)-5.294-5.148-5.963-4.4772.019
净利润/营业总收入 (%)-9.234-10.680-7.815-8.241-1.476

收益指标分析
经营活动净收益/利润总额(%)84.90254.39633.2137.248-334.264
价值变动净收益/利润总额(%)-9.13843.9771.2353.104106.456
营业外收支净额/利润总额(%)-0.1554.3856.32822.52832.797

偿债能力分析
流动比率 (X)1.3751.5221.7161.6071.867
速动比率 (X)1.1591.2841.4711.3781.600
资产负债率 (%)49.61166.00660.65962.18859.407
带息债务/全部投入资本 (%)34.24949.08944.91248.89250.254
股东权益/带息债务 (%)186.50898.970116.15997.70095.165
股东权益/负债合计 (%)105.21350.01559.73656.97161.242
利息保障倍数 (X)-1.297-1.693-1.641-1.1700.685

营运能力分析
应收账款周转天数 (天)334.419279.815295.469274.368226.183
存货周转天数 (天)109.32681.28085.05086.04375.943